266 related articles for article (PubMed ID: 14974118)
41. Deficiency of UDP-GlcNAc:Dolichol Phosphate N-Acetylglucosamine-1 Phosphate Transferase (DPAGT1) causes a novel congenital disorder of Glycosylation Type Ij.
Wu X; Rush JS; Karaoglu D; Krasnewich D; Lubinsky MS; Waechter CJ; Gilmore R; Freeze HH
Hum Mutat; 2003 Aug; 22(2):144-50. PubMed ID: 12872255
[TBL] [Abstract][Full Text] [Related]
42. Mannose metabolism: more than meets the eye.
Sharma V; Ichikawa M; Freeze HH
Biochem Biophys Res Commun; 2014 Oct; 453(2):220-8. PubMed ID: 24931670
[TBL] [Abstract][Full Text] [Related]
43. PMM2 intronic branch-site mutations in CDG-Ia.
Vuillaumier-Barrot S; Le Bizec C; De Lonlay P; Madinier-Chappat N; Barnier A; Dupré T; Durand G; Seta N
Mol Genet Metab; 2006 Apr; 87(4):337-40. PubMed ID: 16376131
[TBL] [Abstract][Full Text] [Related]
44. Prenatal diagnosis for CDG Ia based on post-mortem molecular study of Guthrie card.
Nogueira C; Quelhas D; Vilarinho L
Mol Genet Metab; 2006 Apr; 87(4):379. PubMed ID: 16343971
[No Abstract] [Full Text] [Related]
45. Congenital disorders of glycosylation caused by defects in mannose addition during N-linked oligosaccharide assembly.
Orlean P
J Clin Invest; 2000 Jan; 105(2):131-2. PubMed ID: 10642590
[No Abstract] [Full Text] [Related]
46. Defect of N-glycosylation is not directly related to congenital disorder of glycosylation Ia fibroblast sensitivity to staurosporine-induced cell death.
Lavieu G; Frénoy JP; Codogno P; Botti J
Pediatr Res; 2005 Aug; 58(2):254-7. PubMed ID: 16085795
[TBL] [Abstract][Full Text] [Related]
47. Recurrent thrombo-embolism in a child with a congenital disorder of glycosylation (CDG) type Ib and treatment with mannose.
Tamminga RY; Lefeber DJ; Kamps WA; van Spronsen FJ
Pediatr Hematol Oncol; 2008 Dec; 25(8):762-8. PubMed ID: 19065443
[TBL] [Abstract][Full Text] [Related]
48. Underdiagnosis of mild congenital disorders of glycosylation type Ia.
Giurgea I; Michel A; Le Merrer M; Seta N; de Lonlay P
Pediatr Neurol; 2005 Feb; 32(2):121-3. PubMed ID: 15664773
[TBL] [Abstract][Full Text] [Related]
49. Congenital disorders of glycosylation type Ia as a cause of mirror syndrome.
Wurm D; Löffler G; Lindinger A; Gortner L
J Perinatol; 2007 Dec; 27(12):802-4. PubMed ID: 18034167
[TBL] [Abstract][Full Text] [Related]
50. Protein-Specific Glycoprofiling for Patient Diagnostics.
Lefeber DJ
Clin Chem; 2016 Jan; 62(1):9-11. PubMed ID: 26585926
[No Abstract] [Full Text] [Related]
51. Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia).
Schollen E; Kjaergaard S; Legius E; Schwartz M; Matthijs G
Eur J Hum Genet; 2000 May; 8(5):367-71. PubMed ID: 10854097
[TBL] [Abstract][Full Text] [Related]
52. [Congenital disorder of glycosylation type Ia (CDG Ia) - underdiagnosed entity?].
Sätilä H; Kuusela AL; Pietilä K; Niinikoski H; Keskinen P
Duodecim; 2016; 132(3):253-9. PubMed ID: 26951030
[TBL] [Abstract][Full Text] [Related]
53. Analysis of glycosylation in CDG-Ia fibroblasts by fluorophore-assisted carbohydrate electrophoresis: implications for extracellular glucose and intracellular mannose 6-phosphate.
Gao N; Shang J; Lehrman MA
J Biol Chem; 2005 May; 280(18):17901-9. PubMed ID: 15708848
[TBL] [Abstract][Full Text] [Related]
54. [Carbohydrate-deficient glycoprotein (CDG) syndrome (Jaeken syndrome)].
Ohno K
Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):474-9. PubMed ID: 9645114
[No Abstract] [Full Text] [Related]
55. A rapid mass spectrometric strategy for the characterization of N- and O-glycan chains in the diagnosis of defects in glycan biosynthesis.
Faid V; Chirat F; Seta N; Foulquier F; Morelle W
Proteomics; 2007 Jun; 7(11):1800-13. PubMed ID: 17520685
[TBL] [Abstract][Full Text] [Related]
56. Congenital disorder of glycosylation type Id: clinical phenotype, molecular analysis, prenatal diagnosis, and glycosylation of fetal proteins.
Denecke J; Kranz C; von Kleist-Retzow JCh; Bosse K; Herkenrath P; Debus O; Harms E; Marquardt T
Pediatr Res; 2005 Aug; 58(2):248-53. PubMed ID: 16006436
[TBL] [Abstract][Full Text] [Related]
57. Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder.
Wu X; Steet RA; Bohorov O; Bakker J; Newell J; Krieger M; Spaapen L; Kornfeld S; Freeze HH
Nat Med; 2004 May; 10(5):518-23. PubMed ID: 15107842
[TBL] [Abstract][Full Text] [Related]
58. Novel ALG8 mutations expand the clinical spectrum of congenital disorder of glycosylation type Ih.
Stölting T; Omran H; Erlekotte A; Denecke J; Reunert J; Marquardt T
Mol Genet Metab; 2009 Nov; 98(3):305-9. PubMed ID: 19648040
[TBL] [Abstract][Full Text] [Related]
59. Towards a therapy for phosphomannomutase 2 deficiency, the defect in CDG-Ia patients.
Freeze HH
Biochim Biophys Acta; 2009 Sep; 1792(9):835-40. PubMed ID: 19339218
[TBL] [Abstract][Full Text] [Related]
60. Glycosylation type Ic disorder: idiopathic intracranial hypertension and retinal degeneration.
Kahook MY; Mandava N; Bateman JB; Thomas JA
Br J Ophthalmol; 2006 Jan; 90(1):115-6. PubMed ID: 16361681
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
